Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 5.02, 7.01, 9.01 · 8-K

Cencora, Inc.

CORNYSEEQUITYCurrent

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Director Appointment On September 24, 2026, the Board of Directors (the “Board”) of Cencora, Inc. (the “Company”) appointed Robert E. Sanchez to serve on the Board (the “Appointment”), effective October 1, 2026 (the “Effective Date”).…

Filed Sep 25, 2026Accepted Sep 25, 2026, 8:11 AM EDTCIK 1140859Accession 0001104659-26-110624
Share

Company context

Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #16 on the Global Fortune 500 with more than $300 billion in annual revenue. Learn more at investor.cencora.com

Current securities

Recent company filings

  1. 144 filingSep 16, 2026
  2. 144 filingSep 11, 2026
  3. 144 filingSep 4, 2026
  4. 144 filingSep 1, 2026
  5. 144 filingAug 24, 2026

Registered securities in this filing

Cencora, Inc. · 8-K · Filed 2026-09-25

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock

Symbol
COR
Exchange
NYSE
Classification
COMMON
Status
Current
Filing context

Context: From2026-09-242026-09-24_us-gaap_CommonStockMember

Dimensions: us-gaap:StatementClassOfStockAxis

2.875% Senior Notes due 2028

Symbol
COR28
Exchange
NYSE
Classification
DEBT
Filing context

Context: From2026-09-242026-09-24_custom_Sec2.875SeniorNotesDue2028Member

Dimensions: us-gaap:StatementClassOfStockAxis

3.625% Senior Notes due 2032

Symbol
COR32
Exchange
NYSE
Classification
DEBT
Filing context

Context: From2026-09-242026-09-24_custom_Sec3.625SeniorNotesDue2032Member

Dimensions: us-gaap:StatementClassOfStockAxis

Accession 000110465926110624 · 3 registered-security cover members

Read the exact SEC filing ↗

Disclosure sections

Items 5.02, 7.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Director Appointment On September 24, 2026, the Board of Directors (the “Board”) of Cencora, Inc. (the “Company”) appointed Robert E. Sanchez to serve on the Board (the “Appointment”), effective October 1, 2026 (the “Effective Date”). In connection with the Appointment, the Board increased from ten to eleven members in accordance with the Company’s Amended and Restated Bylaws. Mr. Sanchez will receive the same benefits and compensation as the other non-employee directors on the Board pursuant to the Company’s Compensation Policy for Non-Employee Directors, as described on pages 40 to 41 of the Definitive Proxy Statement on Schedule 14A filed by the Company with the Securities and Exchange Commission on January 22, 2026. Cash compensation is paid on a quarterly basis and the non-employee director annual equity award will be pro-rated for the period beginning on the Effective Date and ending on the date of the Company’s 2027 Annual Meeting of Stockholders. There are no arrangements or understandings between Mr. Sanchez and any other persons pursuant to which Mr. Sanchez was appointed as a director. There are no family relationships between Mr. Sanchez and any director or executive officer of the Company, and the Company has not entered into any transactions with Mr. Sanchez that would require disclosure under Item 404(a) of Regulation S-K. At this time, Mr. Sanchez has not been named to serve on any committees of the Board.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On September 25, 2026, the Company issued a news release announcing the Appointment. A copy of the news release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information disclosed under this Item 7.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information provided herein shall not be deemed incorporated by reference into any filing made under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Filed exhibits (1)
EX-99.1 (by filename) tm2626030d1_ex99-1.htm

Exhibit 99.1 Press Release CENCORA ELECTS ROBERT E. SANCHEZ TO ITS BOARD OF DIRECTORS CONSHOHOCKEN, PA, September 25, 2026 - Cencora, Inc. (NYSE: COR) today announced that its Board of Directors has elected Robert E. Sanchez as a new independent director, effective October 1, 2026. Mr. Sanchez is the Executive Chair of Ryder System, Inc., where he previously served as Chair and Chief Executive Officer until his retirement in March 2026. Prior to being appointed CEO in 2013, Mr. Sanchez spent two decades with Ryder serving in roles of increasing responsibility including President and Chief Operating Officer, President of Global Fleet Management Solutions and Executive Vice President and Chief Financial Officer. “Robert’s experience as a public-company CEO, including his deep understanding of logistics and supply chains, will complement the Board’s skill set as we support Cencora’s pharmaceutical-centric strategy. His appointment reflects the Board’s ongoing commitment to leaders whose perspectives will further the company’s growth ambitions,” said Mark Durcan, Chair of Cencora’s Board of Directors. “Throughout his career at Ryder, Mr. Sanchez has shaped a thoughtful approa…

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.